Shamburg News · 8-K filed Nov 4, 2026, 5:22 PM EST

Summit Therapeutics Files Legality Opinion Tied to Shelf Prospectus Supplement

SMMT · Summit Therapeutics Inc.

  • Other event
  • Financing
  • Materiality: low

Summit Therapeutics Inc. filed a prospectus supplement on November 4, 2026 under its automatic shelf registration statement on Form S-3 (Registration No. 333-296642). This 8-K was filed to submit the opinion of Baker & Hostetler LLP on the legality of the common stock issuance, included as Exhibit 5.1, along with the related consent as Exhibit 23.1.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 8.01, 9.01, accession 0001193125-26-447661.

Written from the filing by Shamburg Markets. Figures are as reported by the company.